Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of synthetic method of L-praziquantel and its intermediate

A technique for the synthesis of L-praziquantel, which is applied in the production of bulk chemicals, organic chemistry, etc., can solve the problems of time-consuming energy consumption, cumbersome process, and the total yield needs to be improved, and achieves mature conditions, simple operation, and high yield. rate-enhancing effect

Active Publication Date: 2017-05-17
TONGLI BIOMEDICAL
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition to the potential environmental protection problems related to the synthesis of praziquantel, the yield and optical purity of the obtained L-praziquantel still need to be improved, and the separated D-praziquantel amine needs to be recovered and racemized before it can be produced. Can be reused, more energy-consuming and time-consuming
[0007] 2. Enzymatic resolution method: Dextromation is required, the process is cumbersome, and the total yield needs to be improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of synthetic method of L-praziquantel and its intermediate
  • A kind of synthetic method of L-praziquantel and its intermediate
  • A kind of synthetic method of L-praziquantel and its intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] The preparation of embodiment 1 recombinant D-amino acid oxidase

[0047] Inoculate a single colony of recombinant Escherichia coli containing the D-amino acid oxidase gene from a glycerol tube or transformation plate into 4 mL liquid LB medium containing (100ug / mL) ampicillin resistance, and activate overnight at 37°C for 12-16 hours , the culture obtained after activation was transferred to 100mL liquid LB medium containing (100ug / mL) ampicillin resistance with 2% inoculum, and cultured at 37°C and 220rpm until OD 600 When the value reaches about 0.6, add the inducer isopropyl-β-D-thiogalactopyranoside to a final concentration of 0.8mmol / L, and continue culturing overnight at 30°C. Collect the cells by centrifugation (4°C, 5000 rpm, 15 min), and suspend the cells with 10 mL of phosphate buffer (100 mM, pH 7.0). Place the cell suspension in an ice bath for 10 minutes, then centrifuge (4°C, 12000rpm, 15min), pre-freeze the supernatant at -20°C overnight, and then free...

Embodiment 2

[0048] Preparation of embodiment 2 intermediate 1-(R)-tetrahydroisoquinoline formic acid ammonium salt

[0049] Dissolve 1.77g (0.01mol) DL-tetrahydroisoquinoline-1-carboxylic acid in 5ml ammonia water (adjust pH to 8.0), add 1.5g (0.05mol) borane-ammonia complex, feed oxygen at a uniform speed, add 88.5 mg of recombinant D-amino acid oxidase and 18 mg of catalase were started to react at 28° C. under stirring, and the reaction progress was detected by HPLC. About 28 hours HPLC test result shows that 1-(S)-tetrahydroisoquinoline-1-formic acid ammonium salt is less than 1%. Stop the reaction, heat to 50-60°C, denature the enzyme protein for more than half an hour, filter the heated reaction through diatomaceous earth to remove the enzyme, add acetone twice the volume of the reaction solution to the filtrate to dilute, collect the precipitated crude solid by filtration, and then pass through Water / acetone (volume ratio 1 / 2) recrystallized to obtain 1.8 g of pure white solid, ...

Embodiment 3

[0051] Preparation of embodiment 3 intermediate 1-(R)-tetrahydroisoquinoline formic acid potassium salt

[0052] 1.77g (0.01mol) DL-tetrahydroisoquinoline-1-carboxylic acid was dissolved in 5ml K 2 HPO 4 -KH 2 PO 4 In the buffer solution (adjust the pH to 8.2), add 2.61g (0.03mol) borane-tert-butylamine complex, feed oxygen at a uniform speed, add 35.5mg recombinant D-amino acid oxidase, 9mg catalase, stir The reaction was started at 35°C, and the reaction progress was detected by HPLC. About 30 hours of HPLC detection results showed that 1-(S)-tetrahydroisoquinoline-1-carboxylic acid potassium salt was less than 1%. Stop the reaction, heat to 50-60°C, and denature the enzyme protein for more than half an hour. The heated reaction is filtered through diatomaceous earth to remove the enzyme, and the filtrate is extracted with toluene (3x5ml), and tert-butylamine (2.1g) is recovered from the toluene phase. Add 2 times the volume of acetone to the extracted water phase to ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an L-praziquantel synthesizing method and a midbody thereof. (IR)-1-carboxymethyl-2- replaces -1,2,3,4-tetrahydroisoquinoline to serve as a raw material, and L-praziquantel is obtained sequentially through condensation acylation reaction, reduction reaction, acylation reaction and ring-closure reaction. By means of the method, L-praziquantel products with higher optical purity can be obtained, cost is lower, and production is more environmentally friendly. A new way is provided for L-praziquantel synthesis, all the steps forming the way are commonly-seen reactions, conditions are mature, and operation is easy. As a whole, by means of the method, the L-praziquantel products with higher optical purity can be obtained, besides, the yield is increased, and production is more environmentally friendly.

Description

technical field [0001] The invention relates to a synthesis method of L-praziquantel ((R)-praziquantel) and an intermediate thereof. Background technique [0002] Praziquantel is a synthetic pyrazine isoquinoline derivative, also known as cyclic praziquantel. It is usually white or off-white crystalline powder with a bitter taste. It is a world-recognized high-efficiency broad-spectrum antiparasitic drug and is widely used in the treatment of Schistosoma japonicum, Schistosoma haematobium, Schistosoma mansoni, clonorchiasis, paragonimiasis, sparganosis monstii, fasciola, echinococcosis, tapeworm and cysticercosis and other diseases. It has the advantages of broad anti-insect spectrum, high curative effect, low toxicity, short course of treatment and convenient use. In addition to being used in humans, it is also widely used in anti-parasitic treatment of animals, poultry, etc. The advent of praziquantel is a major breakthrough in the history of chemotherapy for parasitic d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04C07D217/26
CPCY02P20/55
Inventor 钱明心
Owner TONGLI BIOMEDICAL